Gili Regev‐Yochay
Gili Regev‐Yochay publishes mostly in Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health, on topics such as SARS-CoV-2 and COVID-19 Research, Pneumonia and Respiratory Infections and Respiratory viral infections research.
- World rank
- #176,854 of 7,710,434 ranked researchers
- Rank in Israel
- #1,369 of 38,292
- Works
- 186
- Citations
- 9.3k
- Citations per work
- 50.2
What does Gili Regev‐Yochay research?
Gili Regev‐Yochay's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (5%), Social Sciences (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10455.8%
- Medicine10455.8%
- Everything else6132.6%
- Life Sciences95.0%
- Social Sciences73.5%
- Social Sciences73.5%
- Physical Sciences63.1%
- Mathematics63.1%
- 1Infectious Diseases32% of their works
- 2Epidemiology18% of their works
- 3Public Health, Environmental and Occupational Health6% of their works
- 4Molecular Biology5% of their works
- 5Health4% of their works
- 6Modeling and Simulation3% of their works
Research topics
Which keywords describe Gili Regev‐Yochay's research?
The keywords of their largest research topics: Epidemiology, SARS-CoV-2, ACE2 Receptor, Pandemic, Coronavirus, Vaccine, Antimicrobial Resistance and Community-Acquired Pneumonia.
- wastewater surveillance
- Modeling
- Vaccine Hesitancy
- Thrombosis
- MRSA
- Respiratory Syncytial Virus
- COVID-19
- Community-Acquired Pneumonia
- Vaccine
- Pandemic
- SARS-CoV-2
- Epidemiology
- ACE2 Receptor
- Coronavirus
- Antimicrobial Resistance
- Pneumococcal Conjugate Vaccine
- Human Metapneumovirus
- Clinical Characteristics
- Staphylococcus aureus
- COVID-19 Vaccine
- Diagnostics
- transmission dynamics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Epidemiology1445 topics
- SARS-CoV-21133 topics
- ACE2 Receptor972 topics
- Pandemic972 topics
- Coronavirus711 topic
- Vaccine711 topic
- Antimicrobial Resistance702 topics
- Community-Acquired Pneumonia441 topic
- Pneumococcal Conjugate Vaccine441 topic
- COVID-19322 topics
- Human Metapneumovirus321 topic
- Respiratory Syncytial Virus321 topic
- Clinical Characteristics261 topic
- MRSA261 topic
- Staphylococcus aureus261 topic
- Thrombosis261 topic
- COVID-19 Vaccine181 topic
- Vaccine Hesitancy181 topic
- Diagnostics161 topic
- Modeling161 topic
- transmission dynamics161 topic
- wastewater surveillance161 topic
Where does Gili Regev‐Yochay work?
Gili Regev‐Yochay's main affiliation in the publication record is Sheba Medical Center, Israel.
How many publications and citations does Gili Regev‐Yochay have?
OpenAlex counts 186 works and 9,333 citations for Gili Regev‐Yochay, an h-index of 43, ranking #176,854 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gili Regev‐Yochay. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.